Advertisement
Advertisement
NTRB
Nutriband Inc. Common Stock
3.81
USDSponsored
+0.06
+1.60%
Mar 25, 14:41 UTC -4
Closed
After-Market
3.79
-0.02
-0.39%
NTRB Earnings Reports
Positive Surprise Ratio
NTRB beat 6 of 17 last estimates.
35%
Next Report
Date of Next Report
Apr 27, 2026
Estimate for Q4 26 (Revenue/ EPS)
$780.30K
/-$1.92
Implied change from Q3 26 (Revenue/ EPS)
+125.52%
/+500.00%
Implied change from Q4 25 (Revenue/ EPS)
+21.35%
/+276.47%
Nutriband Inc. Common Stock earnings per share and revenue
On Dec 11, 2025, NTRB reported earnings of -0.32 USD per share (EPS) for Q3 26, beating the estimate of -2.17 USD, resulting in a 85.27% surprise. Revenue reached 346.00 thousand, compared to an expected 688.50 thousand, with a -49.75% difference. The market reacted with a +1.64% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 3 analysts forecast an EPS of -1.92 USD, with revenue projected to reach 780.30 thousand USD, implying an increase of 500.00% EPS, and increase of 125.52% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Talphera, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
Theravance Biopharma, Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
$1.24
Actual
$0.21
Surprise
-83.12%
Relmada Therapeutics, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.14
Actual
-$0.28
Surprise
-103.08%
Context Therapeutics Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.14
Surprise
-29.39%
Avalo Therapeutics, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$1.49
Actual
-$1.12
Surprise
+24.33%
Journey Medical Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.04
Surprise
+31.86%
Surrozen, Inc. Common
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$1.21
Actual
-Surprise
-
Achieve Life Sciences, Inc.
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.28
Surprise
-1.12%
Pyxis Oncology, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.34
Actual
-$0.28
Surprise
+15.55%
Fractyl Health, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
$0.15
Surprise
+181.70%
FAQ
What were Nutriband Inc. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Nutriband Inc. Common Stock reported EPS of -$0.32, beating estimates by 85.27%, and revenue of $346.00K, -49.75% below expectations.
How did the market react to Nutriband Inc. Common Stock's Q3 2026 earnings?
The stock price moved up 1.64%, changed from $4.89 before the earnings release to $4.97 the day after.
When is Nutriband Inc. Common Stock expected to report next?
The next earning report is scheduled for Apr 27, 2026.
What are the forecasts for Nutriband Inc. Common Stock's next earnings report?
Based on 3
analysts, Nutriband Inc. Common Stock is expected to report EPS of -$1.92 and revenue of $780.30K for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement